Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-20

Study Completion Date

2020-08-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate clinical outcome of RFA for small single nodular HCC using no touch technique with separable clustered electrode (Octopus) in a prospective multicenter manner Participating center: Seoul national university hospital, Asan medical center, Samsung medical center, Kunkuk university hospital, St. mary's Seoul hospital

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment

NCT05397860

Hepatocellular Carcinoma Liver Cirrhosis Chronic Liver Disease

UNKNOWN NA

Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma

NCT06682377

Hepatocellular Carcinoma (HCC)

ACTIVE_NOT_RECRUITING NA

RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes

NCT04471272

Radiofrequency Ablation Carcinoma, Hepatocellular

UNKNOWN NA

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies

NCT02683538

Hepatocellular Carcinoma Metastasis Cholangiocarcinoma

COMPLETED PHASE2

Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC

NCT03806218

Hepatocellular Carcinoma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocellular Carcinoma Radiofrequency Ablation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No touch group

RFA for small HCC would be done by using no touch technique

Group Type EXPERIMENTAL

RFA

Intervention Type PROCEDURE

thermal ablation using radiofrequency for HCC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RFA

thermal ablation using radiofrequency for HCC

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Child-Pugh class A liver function
* 1 - 2.5 cm sized Single nodular HCC
* without history of previous HCC treatment or with evidence of no recurrence at least 2 years after previous HCC treatment

Exclusion Criteria

* more than 2 HCC
* tumor size larger than 2.5 cm
* Child-Pugh class B or C liver function
* invisible tumor even after real-time fusion US guidance
* accompanied by vascular invasion or distant metastasis
* presence of coagulopathy defined as platelet count \< 50,000/mm3 and/or PT-INR \> 50%

Minimum Eligible Age

20 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No